Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more
Agilent Technologies Inc (A) - Total Liabilities
Latest total liabilities as of October 2025: $5.99 Billion USD
Based on the latest financial reports, Agilent Technologies Inc (A) has total liabilities worth $5.99 Billion USD as of October 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Agilent Technologies Inc - Total Liabilities Trend (1998–2025)
This chart illustrates how Agilent Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Agilent Technologies Inc Competitors by Total Liabilities
The table below lists competitors of Agilent Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
State Street Corp
NYSE:STT
|
USA | $343.43 Billion |
|
GE HealthCare Technologies Inc.
NASDAQ:GEHC
|
USA | $26.31 Billion |
|
Celestica Inc.
NYSE:CLS
|
USA | $4.99 Billion |
|
Ferrovial SE
NASDAQ:FER
|
USA | $19.75 Billion |
|
Kotak Mahindra Bank Limited
NSE:KOTAKBANK
|
India | ₹7.45 Trillion |
|
Hershey Co
NYSE:HSY
|
USA | $9.10 Billion |
|
Doosan Heavy Ind. & Const.
KO:034020
|
Korea | ₩15.16 Trillion |
|
United Overseas Bank Limited
PINK:UOVEF
|
USA | $487.26 Billion |
Liability Composition Analysis (1998–2025)
This chart breaks down Agilent Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Agilent Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Agilent Technologies Inc (1998–2025)
The table below shows the annual total liabilities of Agilent Technologies Inc from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-10-31 | $5.99 Billion | +0.64% |
| 2024-10-31 | $5.95 Billion | +20.94% |
| 2023-10-31 | $4.92 Billion | -5.91% |
| 2022-10-31 | $5.23 Billion | -1.67% |
| 2021-10-31 | $5.32 Billion | +11.82% |
| 2020-10-31 | $4.75 Billion | +1.06% |
| 2019-10-31 | $4.70 Billion | +18.49% |
| 2018-10-31 | $3.97 Billion | +10.55% |
| 2017-10-31 | $3.59 Billion | +0.50% |
| 2016-10-31 | $3.57 Billion | +7.69% |
| 2015-10-31 | $3.32 Billion | -39.38% |
| 2014-10-31 | $5.47 Billion | +1.41% |
| 2013-10-31 | $5.40 Billion | +0.86% |
| 2012-10-31 | $5.35 Billion | +12.87% |
| 2011-10-31 | $4.74 Billion | -26.61% |
| 2010-10-31 | $6.46 Billion | +26.52% |
| 2009-10-31 | $5.11 Billion | +4.67% |
| 2008-10-31 | $4.88 Billion | +12.92% |
| 2007-10-31 | $4.32 Billion | +16.44% |
| 2006-10-31 | $3.71 Billion | +38.95% |
| 2005-10-31 | $2.67 Billion | -23.43% |
| 2004-10-31 | $3.49 Billion | +0.40% |
| 2003-10-31 | $3.47 Billion | -2.88% |
| 2002-10-31 | $3.58 Billion | +53.67% |
| 2001-10-31 | $2.33 Billion | -24.08% |
| 2000-10-31 | $3.06 Billion | +48.64% |
| 1999-10-31 | $2.06 Billion | +4.94% |
| 1998-10-31 | $1.97 Billion | -- |